id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1524-2161,FDA,FDA-2013-N-1524,Nomination Letter Riboflavin-5-Phosphate Sodium USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:41Z,,0,0,0900006481c24830
FDA-2013-N-1524-2169,FDA,FDA-2013-N-1524,Nomination Letter Selegiline HCl re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:43Z,,0,0,0900006481c24abf
FDA-2013-N-1524-2178,FDA,FDA-2013-N-1524,Nomination Letter Sodium Acetate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24b91
FDA-2013-N-1524-2168,FDA,FDA-2013-N-1524,Nomination Letter SerAqua Serum re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:43Z,,0,0,0900006481c24abe
FDA-2013-N-1524-2155,FDA,FDA-2013-N-1524,Nomination Letter Pyridoxine Hydrochloride USP (Vitamin B6 HCl) re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:37Z,,0,0,0900006481c24803
FDA-2013-N-1524-2173,FDA,FDA-2013-N-1524,Nomination Letter Silver Nitrate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:44Z,,0,0,0900006481c24ac7
FDA-2013-N-1524-2200,FDA,FDA-2013-N-1524,Nomination Letter Spermaceti Synthetic re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce3
FDA-2013-N-1524-2201,FDA,FDA-2013-N-1524,Nomination Letter Spironolactone re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce4
FDA-2013-N-1524-2206,FDA,FDA-2013-N-1524,Nomination Letter SSSF re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:08Z,,0,0,0900006481c24dba
FDA-2013-N-1524-2186,FDA,FDA-2013-N-1524,Nomination Letter Sodium Bromide Gran Pure re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c2d
FDA-2013-N-1524-2166,FDA,FDA-2013-N-1524,Nomination Letter Salicylic Acid re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:43Z,,0,0,0900006481c24835
FDA-2013-N-1524-2159,FDA,FDA-2013-N-1524,Nomination Letter Resorcinol Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:41Z,,0,0,0900006481c2482e
FDA-2013-N-1524-2172,FDA,FDA-2013-N-1524,Nomination Letter Shea Butter re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:44Z,,0,0,0900006481c24ac6
FDA-2013-N-1524-2170,FDA,FDA-2013-N-1524,Nomination Letter Sertraline HCL re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:44Z,,0,0,0900006481c24ac0
FDA-2013-N-1524-2171,FDA,FDA-2013-N-1524,Nomination Letter Sesame Oil re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:44Z,,0,0,0900006481c24ac1
FDA-2013-N-1524-2181,FDA,FDA-2013-N-1524,Nomination Letter Sodium Benzoate Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24b94
FDA-2013-N-1524-2165,FDA,FDA-2013-N-1524,Nomination Letter Safflower Oil re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:42Z,,0,0,0900006481c24834
FDA-2013-N-1524-2160,FDA,FDA-2013-N-1524,Nomination Letter Riboflavin USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:41Z,,0,0,0900006481c2482f
FDA-2013-N-1524-2183,FDA,FDA-2013-N-1524,Nomination Letter Sodium Bicarbonate USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24c29
FDA-2013-N-1524-2205,FDA,FDA-2013-N-1524,Nomination Letter SSSF Omeprazole Kit re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:08Z,,0,0,0900006481c24db9
FDA-2013-N-1524-2180,FDA,FDA-2013-N-1524,Nomination Letter Sodium Acetate USP Trihydrate  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24b93
FDA-2013-N-1524-2199,FDA,FDA-2013-N-1524,Nomination Letter Soybean Oil re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce2
FDA-2013-N-1524-2207,FDA,FDA-2013-N-1524,Nomination Letter Starch Corn re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:08Z,,0,0,0900006481c24dbb
FDA-2013-N-1524-2196,FDA,FDA-2013-N-1524,Nomination Letter Sodium Valproate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:05Z,,0,0,0900006481c24c93
FDA-2013-N-1524-2157,FDA,FDA-2013-N-1524,Nomination Letter Quinacrine Hydrochloride  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:40Z,,0,0,0900006481c24805
FDA-2013-N-1524-2193,FDA,FDA-2013-N-1524,Nomination Letter Sodium Propionate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:52Z,,0,0,0900006481c24c8f
FDA-2013-N-1524-2192,FDA,FDA-2013-N-1524,Nomination Letter Sodium Lauryl Sulfate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:52Z,,0,0,0900006481c24c8e
FDA-2013-N-1524-2202,FDA,FDA-2013-N-1524,Nomination Letter Squalane re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce5
FDA-2013-N-1524-2174,FDA,FDA-2013-N-1524,"Nomination Letter Silicon Dioxide, Colloidal re: Comment from Fagron",Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:48Z,,0,0,0900006481c24b8d
FDA-2013-N-1524-2176,FDA,FDA-2013-N-1524,Nomination Letter Silver Sulfadiazine re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:49Z,,0,0,0900006481c24b8f
FDA-2013-N-1524-2203,FDA,FDA-2013-N-1524,Nomination Letter SSSF Alka re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce7
FDA-2013-N-1524-2204,FDA,FDA-2013-N-1524,Nomination Letter Squaric Acid re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:07Z,,0,0,0900006481c24ce8
FDA-2013-N-1524-2182,FDA,FDA-2013-N-1524,Nomination Letter Sodium Ascorbate USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24c28
FDA-2013-N-1524-2198,FDA,FDA-2013-N-1524,Nomination Letter Sorbitol Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:06Z,,0,0,0900006481c24ce1
FDA-2013-N-1524-2162,FDA,FDA-2013-N-1524,Nomination Letter Rifampin USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:42Z,,0,0,0900006481c24831
FDA-2013-N-1524-2156,FDA,FDA-2013-N-1524,Nomination Letter Pyruvic Acid re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:38Z,,0,0,0900006481c24804
FDA-2013-N-1524-2184,FDA,FDA-2013-N-1524,Nomination Letter Sodium Bisulfite USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c2a
FDA-2013-N-1524-2185,FDA,FDA-2013-N-1524,Nomination Letter Sodium Borate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c2b
FDA-2013-N-1524-2197,FDA,FDA-2013-N-1524,Nomination Letter Sorbic Acid Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:06Z,,0,0,0900006481c24c94
FDA-2013-N-1524-2167,FDA,FDA-2013-N-1524,Nomination Letter Scopolamine re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:43Z,,0,0,0900006481c24836
FDA-2013-N-1524-2188,FDA,FDA-2013-N-1524,Nomination Letter Sodium Chloride USP Granular  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c2f
FDA-2013-N-1524-2164,FDA,FDA-2013-N-1524,Nomination Letter Saccharin Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:42Z,,0,0,0900006481c24833
FDA-2013-N-1524-2158,FDA,FDA-2013-N-1524,Nomination Letter Rapid Dissolve Tablet Powder re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:40Z,,0,0,0900006481c2482d
FDA-2013-N-1524-2190,FDA,FDA-2013-N-1524,Nomination Letter Sodium Citrate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c8b
FDA-2013-N-1524-2194,FDA,FDA-2013-N-1524,Nomination Letter Sodium Phosphate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:52Z,,0,0,0900006481c24c90
FDA-2013-N-1524-2195,FDA,FDA-2013-N-1524,Nomination Letter Sodium Sulfite re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:40:05Z,,0,0,0900006481c24c92
FDA-2013-N-1524-2163,FDA,FDA-2013-N-1524,Nomination Letter Rose Oil Artificial re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T14:33:42Z,,0,0,0900006481c24832
FDA-2013-N-1524-2191,FDA,FDA-2013-N-1524,Nomination Letter Sodium Hydroxide NF Pellets re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:52Z,,0,0,0900006481c24c8d
FDA-2013-N-1524-2189,FDA,FDA-2013-N-1524,Nomination Letter Sodium Fluoride Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c31
FDA-2013-N-1524-2177,FDA,FDA-2013-N-1524,Nomination Letter Simethicone re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:49Z,,0,0,0900006481c24b90
FDA-2013-N-1524-2179,FDA,FDA-2013-N-1524,Nomination Letter Simple Syrup re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:50Z,,0,0,0900006481c24b92
FDA-2013-N-1524-2175,FDA,FDA-2013-N-1524,Nomination Letter Silver Protein Mild re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:49Z,,0,0,0900006481c24b8e
FDA-2013-N-1524-2187,FDA,FDA-2013-N-1524,Nomination Letter Sodium Butyrate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-09T04:00:00Z,2015,10,,,2015-10-09T15:18:51Z,,0,0,0900006481c24c2e
FDA-2013-N-1524-2148,FDA,FDA-2013-N-1524,"Nomination Letter Progesterone, Micronized re: Comment from Fagron",Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:55Z,,0,0,0900006481c247fc
FDA-2013-N-1524-2123,FDA,FDA-2013-N-1524,Nomination Letter Polysorbate 80 re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:32Z,,0,0,0900006481c1d85f
FDA-2013-N-1524-2122,FDA,FDA-2013-N-1524,Nomination Letter Polysorbate 20 re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:32Z,,0,0,0900006481c1d85e
FDA-2013-N-1524-2105,FDA,FDA-2013-N-1524,Nomination Letter Phenobarbital USP CIV  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:11Z,,0,0,0900006481c1d710
FDA-2013-N-1524-2127,FDA,FDA-2013-N-1524,Nomination Letter Potassium Chloride USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:33Z,,0,0,0900006481c1d425
FDA-2013-N-1524-2116,FDA,FDA-2013-N-1524,Nomination Letter Piroxicam re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d807
FDA-2013-N-1524-2120,FDA,FDA-2013-N-1524,Nomination Letter Polybase re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:30Z,,0,0,0900006481c1d85b
FDA-2013-N-1524-2124,FDA,FDA-2013-N-1524,Nomination Letter Potassium Hydroxide re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:33Z,,0,0,0900006481c1d861
FDA-2013-N-1524-2143,FDA,FDA-2013-N-1524,Nomination Letter Pregnenolone re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:54Z,,0,0,0900006481c24a3c
FDA-2013-N-1524-2095,FDA,FDA-2013-N-1524,Nomination Letter Pentravan re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:49Z,,0,0,0900006481c1a814
FDA-2013-N-1524-2139,FDA,FDA-2013-N-1524,Nomination Letter Prednisolone Acetate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:53Z,,0,0,0900006481c24a38
FDA-2013-N-1524-2145,FDA,FDA-2013-N-1524,Nomination Letter Prilocaine Hydrochloride USP  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:54Z,,0,0,0900006481c24a3e
FDA-2013-N-1524-2146,FDA,FDA-2013-N-1524,Nomination Letter Prochlorperazine Maleate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:55Z,,0,0,0900006481c24a3f
FDA-2013-N-1524-2125,FDA,FDA-2013-N-1524,Nomination Letter Potassium Bicarbonate Gran re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:33Z,,0,0,0900006481c1d862
FDA-2013-N-1524-2126,FDA,FDA-2013-N-1524,Nomination Letter Potassium Bromide Cry re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:33Z,,0,0,0900006481c1d424
FDA-2013-N-1524-2154,FDA,FDA-2013-N-1524,Nomination Letter Propylparaben re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:56Z,,0,0,0900006481c24802
FDA-2013-N-1524-2150,FDA,FDA-2013-N-1524,"Nomination Letter Progesterone, Wettable re: Comment from Fagron",Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:55Z,,0,0,0900006481c247fe
FDA-2013-N-1524-2093,FDA,FDA-2013-N-1524,Nomination Letter Petrolatum Yellow re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:48Z,,0,0,0900006481c1a817
FDA-2013-N-1524-2110,FDA,FDA-2013-N-1524,Nomination Letter Phenyl Salicylate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d715
FDA-2013-N-1524-2109,FDA,FDA-2013-N-1524,Nomination Letter Phentolamine Mesylate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d714
FDA-2013-N-1524-2131,FDA,FDA-2013-N-1524,Nomination Letter Potassium Hydroxide Pellets  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:34Z,,0,0,0900006481c1d429
FDA-2013-N-1524-2130,FDA,FDA-2013-N-1524,Nomination Letter Potassium Gluconate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:33Z,,0,0,0900006481c1d428
FDA-2013-N-1524-2100,FDA,FDA-2013-N-1524,Nomination Letter Pharmabase Cosmetic Cream Heavy re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:10Z,,0,0,0900006481c1d245
FDA-2013-N-1524-2142,FDA,FDA-2013-N-1524,Nomination Letter Prednisolone Sodium re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:54Z,,0,0,0900006481c24a3b
FDA-2013-N-1524-2153,FDA,FDA-2013-N-1524,Nomination Letter Psyllium Husk Pwd re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:56Z,,0,0,0900006481c24801
FDA-2013-N-1524-2149,FDA,FDA-2013-N-1524,Nomination Letter Promethazine HCl USP re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:55Z,,0,0,0900006481c247fd
FDA-2013-N-1524-2121,FDA,FDA-2013-N-1524,Nomination Letter Polyoxyl 40 Stearate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:32Z,,0,0,0900006481c1d85c
FDA-2013-N-1524-2113,FDA,FDA-2013-N-1524,Nomination Letter Phenytoin re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d804
FDA-2013-N-1524-2103,FDA,FDA-2013-N-1524,Nomination Letter Pharmabase Vaginal Cream re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:11Z,,0,0,0900006481c1d70d
FDA-2013-N-1524-2108,FDA,FDA-2013-N-1524,Nomination Letter Phentermine HCl re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:11Z,,0,0,0900006481c1d713
FDA-2013-N-1524-2097,FDA,FDA-2013-N-1524,Nomination Letter Pentravan Plus re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:50Z,,0,0,0900006481c1a812
FDA-2013-N-1524-2096,FDA,FDA-2013-N-1524,Nomination Letter Peruvian Balsam Plus re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:50Z,,0,0,0900006481c1a813
FDA-2013-N-1524-2112,FDA,FDA-2013-N-1524,Nomination Letter Phenytoin Sodium re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d802
FDA-2013-N-1524-2117,FDA,FDA-2013-N-1524,Nomination Letter Podophyllum Resin Usp re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:13Z,,0,0,0900006481c1d808
FDA-2013-N-1524-2104,FDA,FDA-2013-N-1524,Nomination Letter Pharmabase CC NEC  re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:11Z,,0,0,0900006481c1d70e
FDA-2013-N-1524-2135,FDA,FDA-2013-N-1524,Nomination Letter Potassium Sorbate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:34Z,,0,0,0900006481c1d42d
FDA-2013-N-1524-2141,FDA,FDA-2013-N-1524,Nomination Letter Prednisone micr re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:54Z,,0,0,0900006481c24a3a
FDA-2013-N-1524-2151,FDA,FDA-2013-N-1524,Nomination Letter Propranolol HCl re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:56Z,,0,0,0900006481c247ff
FDA-2013-N-1524-2099,FDA,FDA-2013-N-1524,Nomination Letter Peg re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:50Z,,0,0,0900006481c1a810
FDA-2013-N-1524-2111,FDA,FDA-2013-N-1524,Nomination Letter Phenylephrine re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d801
FDA-2013-N-1524-2114,FDA,FDA-2013-N-1524,Nomination Letter Phosphatidyl Serine 20% re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:12Z,,0,0,0900006481c1d805
FDA-2013-N-1524-2119,FDA,FDA-2013-N-1524,Nomination Letter Poloxamer 407 re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:29Z,,0,0,0900006481c1d85a
FDA-2013-N-1524-2106,FDA,FDA-2013-N-1524,Nomination Letter Phenol re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:14:11Z,,0,0,0900006481c1d711
FDA-2013-N-1524-2133,FDA,FDA-2013-N-1524,Nomination Letter Potassium Permanganate re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T15:54:34Z,,0,0,0900006481c1d42b
FDA-2013-N-1524-2136,FDA,FDA-2013-N-1524,Nomination Letter Povidone K-30 re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:52Z,,0,0,0900006481c24070
FDA-2013-N-1524-2140,FDA,FDA-2013-N-1524,Nomination Letter Prednisolone Anhy Micro re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T16:29:53Z,,0,0,0900006481c24a39
FDA-2013-N-1524-2094,FDA,FDA-2013-N-1524,Nomination Letter Petrolatum White re: Comment from Fagron,Supporting & Related Material,Background Material,2015-10-08T04:00:00Z,2015,10,,,2015-10-08T14:23:48Z,,0,0,0900006481c1a815